Foresee Pharmaceuticals Expands Reach with New Licensing Deal for MMP-12 Inhibitors Foresee Pharmaceuticals signs a global licensing agreement with Primevera Therapeutics for MMP-12 inhibitors, emphasizing growth and financial stability.

Foresee Pharmaceuticals Expands Reach with New Licensing Deal for MMP-12 Inhibitors #Taipei #USA #Foresee_Pharmaceuticals #Primevera_Therapeutics #MMP-12_Inhibitors

Foresee Pharmaceuticals Enters Global Licensing Agreement with Primevera for MMP-12 Inhibitors Foresee Pharmaceuticals announces its exclusive global licensing deal with Primevera Therapeutics for MMP-12 inhibitors, enhancing its financial stability and profitability.

Foresee Pharmaceuticals Enters Global Licensing Agreement with Primevera for MMP-12 Inhibitors #Taiwan #Taipei #Foresee_Pharmaceuticals #Primevera_Therapeutics #MMP-12_Inhibitors